The Association of Serum Leptin with Mortality in Older Adults

Objective Elevated levels of serum leptin are associated with increased adiposity and production of pro-inflammatory cytokines. Both cytokines and body adiposity have been shown to predict cardiovascular events and mortality. The primary objective of the present study is to explore the associations between serum leptin and all-cause mortality and mortality from cardiovascular disease (CVD) over a span of 10 years, controlling for body adiposity and proinflammatory cytokines. Methods The Health, Aging and Body Composition (Health ABC) study is a prospective cohort of 3,075 older adults aged 70 to 79 years. This analysis includes 2,919 men and women with complete serum leptin and vital status data. Data on all-cause mortality and incident cardiovascular events (including Coronary Heart Disease and Congestive Heart Failure) were collected over 10 years of follow-up (mean 8.4 years). Results Women with leptin in quartile 2 and 3 were at lower risk of all-cause mortality, and those with leptin in quartile 2 were at lower risk of mortality from CVD as compared to women with lowest leptin values when adjusted for age, race, site, years of education, alcohol use, smoking, and physical activity. When these associations were additionally adjusted for body fat, C-reactive protein and pro-inflammatory cytokines, women with leptin values in quartile 3 were at lower risk of all-cause mortality and women with leptin in quartile 2 and 3 were at lower risk of mortality from CVD than women with lowest leptin values. These associations were not significant among men after adjusting for body fat and cytokines. Conclusions The present study suggests that moderately elevated concentrations of serum leptin are independently associated with lower risk of all-cause mortality and CVD-related mortality among older women. Among men, serum leptin is not associated with reduced risk of all-cause and CVD mortality after controlling for body fat and cytokines.

[1]  Olia Papacosta,et al.  The obesity paradox in men with coronary heart disease and heart failure: The role of muscle mass and leptin , 2014, International journal of cardiology.

[2]  S. Cummings,et al.  Adipose tissue density, a novel biomarker predicting mortality risk in older adults. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  S. Satterfield,et al.  Hyperleptinemia, Adiposity, and Risk of Metabolic Syndrome in Older Adults , 2011, Journal of nutrition and metabolism.

[4]  E. Vittinghoff,et al.  Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study. , 2011, Atherosclerosis.

[5]  P. Macfarlane,et al.  Leptin Predicts Diabetes but Not Cardiovascular Disease , 2009, Diabetes Care.

[6]  C. Mantzoros,et al.  Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case–control study , 2009, Cancer Causes & Control.

[7]  D. Levy,et al.  Plasma Leptin Levels and Incidence of Heart Failure, Cardiovascular Disease, and Total Mortality in Elderly Individuals , 2008, Diabetes Care.

[8]  Heike Münzberg,et al.  Mechanisms of leptin action and leptin resistance. , 2008, Annual review of physiology.

[9]  Cheuk-Kwan Sun,et al.  Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury. , 2008, Cardiovascular research.

[10]  S. Kritchevsky,et al.  Body mass index and serum leptin concentration independently estimate percentage body fat in older adults. , 2007, The American journal of clinical nutrition.

[11]  F. Hu,et al.  Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study , 2007, Diabetologia.

[12]  G. Lip,et al.  Adiponectin and hypertension: a putative link between adipocyte function and atherosclerotic risk? , 2007, Journal of Human Hypertension.

[13]  E. Barrett-Connor,et al.  Cardiovascular Death and the Metabolic Syndrome , 2006, Diabetes Care.

[14]  V. Somers,et al.  Leptin receptor and functional effects of leptin in human endothelial progenitor cells. , 2005, Atherosclerosis.

[15]  U. Ekelund,et al.  Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. , 2005, Obesity research.

[16]  P. Gorden,et al.  Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. , 2005, Diabetes.

[17]  F. Casanueva,et al.  Leptin, from fat to inflammation: old questions and new insights , 2005, FEBS letters.

[18]  S. Rubin,et al.  Weight-loss intention in the well-functioning, community-dwelling elderly: associations with diet quality, physical activity, and weight change. , 2004, The American journal of clinical nutrition.

[19]  A. Marciniak,et al.  Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. , 2004, Life sciences.

[20]  M. Westerterp-Plantenga,et al.  Leptin and the proinflammatory state associated with human obesity. , 2004, The Journal of clinical endocrinology and metabolism.

[21]  Jun Ren,et al.  Leptin and hyperleptinemia - from friend to foe for cardiovascular function. , 2004, The Journal of endocrinology.

[22]  L. Luzi,et al.  Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. , 2003, Diabetes care.

[23]  J. Hare,et al.  Disruption of Leptin Signaling Contributes to Cardiac Hypertrophy Independently of Body Weight in Mice , 2002, Circulation.

[24]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[25]  L. Wilkins.  I. Background and Introduction , 2002 .

[26]  M. Sánchez-Rodríguez,et al.  Overweight, waist circumference, age, gender, and insulin resistance as risk factors for hyperleptinemia. , 2002, Obesity research.

[27]  P. Havel.  Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin , 2002, Current opinion in lipidology.

[28]  F. Perfetto,et al.  Leukocytosis and hyperleptinemia in obesity: is there a link? , 2002, Haematologica.

[29]  L. Fratta,et al.  Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. , 2002, Diabetes.

[30]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[31]  N. Sattar,et al.  Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) , 2001, Circulation.

[32]  Y. Higami,et al.  Leptin signaling and aging: insight from caloric restriction , 2001, Mechanisms of Ageing and Development.

[33]  J. Everhart,et al.  Leptin concentrations in the United States: relations with demographic and anthropometric measures. , 2001, The American journal of clinical nutrition.

[34]  R. Leibel,et al.  Sexual dimorphism in circulating leptin concentrations is not accounted for by differences in adipose tissue distribution , 2001, International Journal of Obesity.

[35]  Y. Kaneda,et al.  Leptin Induces Mitochondrial Superoxide Production and Monocyte Chemoattractant Protein-1 Expression in Aortic Endothelial Cells by Increasing Fatty Acid Oxidation via Protein Kinase A* , 2001, The Journal of Biological Chemistry.

[36]  Bente Klarlund Pedersen,et al.  Aging and proinflammatory cytokines , 2001, Current opinion in hematology.

[37]  W. Buurman,et al.  Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals , 2001, International Journal of Obesity.

[38]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[39]  M. Schroll,et al.  TNF-alpha, leptin, and lymphocyte function in human aging. , 2000, Life sciences.

[40]  F. Casanueva,et al.  Elevated serum leptin concentrations induced by experimental acute inflammation. , 2000, Life sciences.

[41]  L. Fratta,et al.  Leptin induces direct vasodilation through distinct endothelial mechanisms. , 2000, Diabetes.

[42]  M. Schuster,et al.  Geriatric cachexia: the role of cytokines. , 1999, The American journal of clinical nutrition.

[43]  R. Busse,et al.  Leptin induces oxidative stress in human endothelial cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  L. Orci,et al.  Regulation of fatty acid homeostasis in cells: novel role of leptin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Ross,et al.  Serum leptin in elderly people: associations with sex hormones, insulin, and adipose tissue volumes. , 1999, Obesity research.

[46]  I. Godsland,et al.  Hyperleptinemia as a Component of a Metabolic Syndrome of Cardiovascular Risk , 1998 .

[47]  G. Dagenais,et al.  Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study , 1998, Diabetes Care.

[48]  K. Nair,et al.  Disruption of the relationship between fat content and leptin levels with aging in humans. , 1998, The Journal of clinical endocrinology and metabolism.

[49]  I. Godsland,et al.  Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[50]  Patricia R. Johnson,et al.  Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. , 1996, The Journal of clinical endocrinology and metabolism.

[51]  A S Leon,et al.  A questionnaire for the assessment of leisure time physical activities. , 1978, Journal of chronic diseases.